To establish a consensus on clinical recommendation of oral supplementation for patients with or at risk of developing age-related macular degeneration (AMD), from the perspective of the Age-Related Eye Disease Study 2 (AREDS 2) and other studies.
Life After AREDS 2: What Should We Recommend to Patients With or at Risk of Amd?
Publication Date
Author
Langis Michaud, Julie Brûlé, Jean-Sebastien Dufour, Pierre Forcier, Guillaume Fortin, Kevin Messier, Marc-André Rhéaume, Yvon Rhéaume, Patrick Simard, Christina Clark
